Compile Data Set for Download or QSAR
Report error Found 176 Enz. Inhib. hit(s) with all data for entry = 7241
TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183069(US9150544, 103)
Affinity DataIC50: 1.40nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182990(US9150544, 24)
Affinity DataIC50: 2nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182980(US9150544, 14)
Affinity DataIC50: 4nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183016(US9150544, 50)
Affinity DataIC50: 5nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183014(US9150544, 48)
Affinity DataIC50: 6.40nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182987(US9150544, 21)
Affinity DataIC50: 8nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183012(US9150544, 46)
Affinity DataIC50: 8.40nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182996(US9150544, 30)
Affinity DataIC50: 12nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183010(US9150544, 44)
Affinity DataIC50: 14nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183028(US9150544, 62)
Affinity DataIC50: 16nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182983(US9150544, 17)
Affinity DataIC50: 17nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183058(US9150544, 92)
Affinity DataIC50: 19nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182977(US9150544, 11)
Affinity DataIC50: 21nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182979(US9150544, 13)
Affinity DataIC50: 21nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183006(US9150544, 40)
Affinity DataIC50: 22nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183061(US9150544, 95)
Affinity DataIC50: 25nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183019(US9150544, 53)
Affinity DataIC50: 27nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182975(US9150544, 9)
Affinity DataIC50: 29nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM60667(US9150544, 34 | BDBM183000)
Affinity DataIC50: 32nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM60667(US9150544, 34 | BDBM183000)
Affinity DataIC50: 32nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183045(US9150544, 79)
Affinity DataIC50: 33nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182994(US9150544, 28)
Affinity DataIC50: 34nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183026(US9150544, 60)
Affinity DataIC50: 34nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183024(US9150544, 58)
Affinity DataIC50: 35nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183068(US9150544, 102)
Affinity DataIC50: 37nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183029(US9150544, 63)
Affinity DataIC50: 42nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183062(US9150544, 96)
Affinity DataIC50: 42nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182978(US9150544, 12)
Affinity DataIC50: 43nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183007(US9150544, 41)
Affinity DataIC50: 47nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182998(US9150544, 32)
Affinity DataIC50: 48nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183009(US9150544, 77 | US9150544, 43)
Affinity DataIC50: 60nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM183011(US9150544, 45)
Affinity DataIC50: 67nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183049(US9150544, 83)
Affinity DataIC50: 69nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM182983(US9150544, 17)
Affinity DataIC50: 70nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183045(US9150544, 79)
Affinity DataIC50: 70nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182988(US9150544, 22)
Affinity DataIC50: 73nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182982(US9150544, 16)
Affinity DataIC50: 74nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183022(US9150544, 56)
Affinity DataIC50: 76nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183061(US9150544, 95)
Affinity DataIC50: 80nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183062(US9150544, 96)
Affinity DataIC50: 83nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183019(US9150544, 53)
Affinity DataIC50: 84nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183047(US9150544, 81)
Affinity DataIC50: 86nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182976(US9150544, 10)
Affinity DataIC50: 86nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183028(US9150544, 62)
Affinity DataIC50: 92nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182991(US9150544, 25)
Affinity DataIC50: 97nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM182967(US9150544, 1)
Affinity DataIC50: 100nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183006(US9150544, 40)
Affinity DataIC50: 100nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor IX(Human)
Sanofi

US Patent
LigandPNGBDBM183040(US9150544, 74)
Affinity DataIC50: 100nMAssay Description:The compounds according to the invention are tested in a range of concentrations (4.9 nM to 5 µM final) and deposited in a proportion of 25 µl per we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182974(US9150544, 8)
Affinity DataIC50: 100nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

TargetCoagulation factor X(Human)
Sanofi

US Patent
LigandPNGBDBM182992(US9150544, 26)
Affinity DataIC50: 100nMpH: 7.0Assay Description:The compounds according to the invention are tested in a range of concentrations (10pM to 10 µM final) in assay buffer (50 mM TRIS, 100 mM NaCl, 0.1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2016
Entry Details
Go to US Patent

Displayed 1 to 50 (of 176 total ) | Next | Last >>
Jump to: